Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $642,220 (100.0% shares, 0.0% debt)

Holdings (32)

APLS APELLIS PHARMACEUTICALS INC 25.4%
Value ($000) $163,404 Shares 3,160,000 Est. Cost $48.04 Unrealized +10.4%
CHINOOK THERAPEUTICS INC 10.4%
Value ($000) $66,855 Shares 2,551,703 Est. Cost $16.88 Unrealized
VERONA PHARMA PLC 10.0%
Value ($000) $64,489 Shares 2,468,000 Est. Cost $17.59 Unrealized
RCUS ARCUS BIOSCIENCES INC 8.0%
Value ($000) $51,342 Shares 2,482,700 Est. Cost $33.27 Unrealized -17.3%
MIRATI THERAPEUTICS INC 5.3%
Value ($000) $33,983 Shares 750,000 Est. Cost $52.54 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 5.3%
Value ($000) $33,936 Shares 761,398 Est. Cost $25.60 Unrealized +39.5%
IVERIC BIO INC 4.3%
Value ($000) $27,362 Shares 1,278,000 Est. Cost $21.41 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 3.7%
Value ($000) $24,075 Shares 824,200 Est. Cost $23.04 Unrealized 0.0%
TNDM TANDEM DIABETES CARE INC 3.3%
Value ($000) $21,348 Shares 474,929 Est. Cost $54.82 Unrealized -17.4%
AEROVATE THERAPEUTICS INC 2.8%
Value ($000) $18,216 Shares 621,712 Est. Cost $29.30 Unrealized
XBI SPDR SER TR 2.6%
Value ($000) $16,552 Shares 199,417 Est. Cost $77.85 Unrealized
VERA VERA THERAPEUTICS INC 2.0%
Value ($000) $12,871 Shares 665,156 Est. Cost $16.05 Unrealized +12.8%
INTRA-CELLULAR THERAPIES INC 1.8%
Value ($000) $11,693 Shares 220,953 Est. Cost $46.53 Unrealized
CYMABAY THERAPEUTICS INC 1.8%
Value ($000) $11,657 Shares 1,859,200 Est. Cost $6.27 Unrealized
FDMT 4D MOLECULAR THERAPEUTICS IN 1.7%
Value ($000) $11,105 Shares 499,996 Est. Cost $30.23 Unrealized -48.9%
ALPINE IMMUNE SCIENCES INC 1.4%
Value ($000) $9,004 Shares 1,225,000 Est. Cost $7.20 Unrealized
ITEOS THERAPEUTICS INC 1.4%
Value ($000) $8,691 Shares 445,000 Est. Cost $19.53 Unrealized
VKTX VIKING THERAPEUTICS INC 1.3%
Value ($000) $8,183 Shares 870,500 Est. Cost $4.46 Unrealized 0.0%
RNAM AVIDITY BIOSCIENCES INC 1.1%
Value ($000) $7,204 Shares 324,629 Est. Cost $27.48 Unrealized -45.7%
BBIO BRIDGEBIO PHARMA INC 1.1%
Value ($000) $7,115 Shares 933,743 Est. Cost $38.67 Unrealized -75.2%
STOK STOKE THERAPEUTICS INC 1.1%
Value ($000) $7,047 Shares 763,456 Est. Cost $27.91 Unrealized -62.7%
XLO XILIO THERAPEUTICS INC 1.0%
Value ($000) $6,523 Shares 2,425,000 Est. Cost $2.77 Unrealized -13.1%
89BIO INC 0.8%
Value ($000) $4,837 Shares 380,000 Est. Cost $12.73 Unrealized
GOSS GOSSAMER BIO INC 0.7%
Value ($000) $4,249 Shares 1,958,069 Est. Cost $9.60 Unrealized -14.2%
MIRM MIRUM PHARMACEUTICALS INC 0.3%
Value ($000) $1,950 Shares 100,000 Est. Cost $24.08 Unrealized -17.9%
PRAXIS PRECISION MEDICINES I 0.3%
Value ($000) $1,904 Shares 800,000 Est. Cost $2.38 Unrealized
DXCM DEXCOM INC 0.3%
Value ($000) $1,699 Shares 15,000 Est. Cost $84.70 Unrealized +29.6%
PROMETHEUS BIOSCIENCES INC 0.3%
Value ($000) $1,650 Shares 15,000 Est. Cost $110.00 Unrealized
JOUNCE THERAPEUTICS INC 0.2%
Value ($000) $1,554 Shares 1,400,000 Est. Cost $2.34 Unrealized
MREO MEREO BIOPHARMA GROUP PLC 0.1%
Value ($000) $750 Shares 1,000,000 Est. Cost $1.12 Unrealized
NUVL NUVALENT INC 0.1%
Value ($000) $745 Shares 25,000 Est. Cost $16.74 Unrealized +66.6%
IPSC CENTURY THERAPEUTICS INC 0.0%
Value ($000) $231 Shares 45,000 Est. Cost $24.92 Unrealized -62.1%